CoChat

Cellular Senescence in Lung Fibrosis

Open access
Hernandez-Gonzalez, Fernanda, Faner, Rosa, Rojas, Mauricio, Agustí, Alvar, Serrano, Manuel, Sellarés, Jacobo · 2021 · International Journal of Molecular Sciences
Cited by 76

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Fibrosing interstitial lung diseases (ILDs) are chronic and ultimately fatal age-related lung diseases characterized by the progressive and irreversible accumulation of scar tissue in the lung parenchyma. Over the past years, significant progress has been made in our incomplete understanding of the pathobiology underlying fibrosing ILDs, in particular in relation to diverse age-related processes and cell perturbations that seem to lead to maladaptation to stress and susceptibility to lung fibrosis. Growing evidence suggests that a specific biological phenomenon known as cellular senescence plays an important role in the initiation and progression of pulmonary fibrosis. Cellular senescence is defined as a cell fate decision caused by the accumulation of unrepairable cellular damage and is characterized by an abundant pro-inflammatory and pro-fibrotic secretome. The senescence response has been widely recognized as a beneficial physiological mechanism during development and in tumour suppression. However, recent evidence strengthens the idea that it also drives degenerative processes such as lung fibrosis, most likely by promoting molecular and cellular changes in chronic fibrosing processes. Here, we review how cellular senescence may contribute to lung fibrosis pathobiology, and we highlight current and emerging therapeutic approaches to treat fibrosing ILDs by targeting cellular senescence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22137012

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 49

  1. Wynn, 2007, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases, J. Clin. Investig., 117, 524, 10.1172/JCI31487 · DOI · Paper page
  2. Travis, 2013, An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am. J. Respir. Crit. Care Med., 188, 733, 10.1164/rccm.201308-1483ST · DOI · Paper page
  3. Kapetanaki, 2013, Influence of age on wound healing and fibrosis, J. Pathol., 229, 310, 10.1002/path.4122 · DOI · Paper page
  4. Wynn, 2011, Integrating mechanisms of pulmonary fibrosis, J. Exp. Med., 208, 1339, 10.1084/jem.20110551 · DOI · Paper page
  5. Barkauskas, 2014, Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis, Am. J. Physiol. Cell Physiol., 306, C987, 10.1152/ajpcell.00321.2013 · DOI · Paper page
  6. Hayflick, 1965, The Limited in Vitro Lifetime of Human Diploid Cell Strains, Exp. Cell Res., 37, 614, 10.1016/0014-4827(65)90211-9 · DOI · Paper page
  7. Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
  8. Hornsby, 2002, Cellular senescence and tissue aging in vivo, J. Gerontol. A Biol. Sci. Med. Sci., 57, B251, 10.1093/gerona/57.7.B251 · DOI · Paper page
  9. Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 · DOI · Paper page
  10. Hamsanathan, 2019, Cellular Senescence: The Trojan Horse in Chronic Lung Diseases, Am. J. Respir. Cell Mol. Biol., 61, 21, 10.1165/rcmb.2018-0410TR · DOI · Paper page
  11. Selman, 2014, Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model, Am. J. Respir. Crit. Care Med., 189, 1161, 10.1164/rccm.201312-2221PP · DOI · Paper page
  12. Pardo, 2016, Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis, Ann. Am. Thorac. Soc., 13, S417, 10.1513/AnnalsATS.201605-341AW · DOI · Paper page
  13. Mora, 2017, Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease, Nat. Rev. Drug Discov., 16, 755, 10.1038/nrd.2017.170 · DOI · Paper page
  14. Kropski, 2014, A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia, Chest, 146, e1, 10.1378/chest.13-2224 · DOI
  15. Borie, 2009, Prevalence of telomere shortening in familial and sporadic pulmonary fibrosis is increased in men, Am. J. Respir. Crit. Care Med., 179, 1073, 10.1164/ajrccm.179.11.1073 · DOI
  16. Borie, 2018, Clinical implications of telomere dysfunction in lung fibrosis, Curr. Opin. Pulm Med., 24, 440, 10.1097/MCP.0000000000000506 · DOI
  17. Lopez, 2019, Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis, Respirology, 24, 146, 10.1111/resp.13423 · DOI
  18. Wiley, 2019, Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis, JCI Insight, 4, e130056, 10.1172/jci.insight.130056 · DOI · Paper page
  19. Chondrogianni, 2015, Proteasome activation: An innovative promising approach for delaying aging and retarding age-related diseases, Ageing Res. Rev., 23, 37, 10.1016/j.arr.2014.12.003 · DOI
  20. Kropski, 2015, Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease, Am. J. Respir. Crit. Care Med., 191, 417, 10.1164/rccm.201406-1162OC · DOI · Paper page
  21. Tanjore, 2013, Endoplasmic reticulum stress as a pro-fibrotic stimulus, Biochim. Biophys. Acta, 1832, 940, 10.1016/j.bbadis.2012.11.011 · DOI · Paper page
  22. Baker, 2014, Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases, Physiol. Res., 63, 311, 10.33549/physiolres.932607 · doi:10.33549/physiolres.932607
  23. Semren, 2015, Regulation of 26S Proteasome Activity in Pulmonary Fibrosis, Am. J. Respir. Crit. Care Med., 192, 1089, 10.1164/rccm.201412-2270OC · DOI
  24. Jorgensen, E., Stinson, A., Shan, L., Yang, J., Gietl, D., and Albino, A.P. (2008). Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer, 8. · DOI · Paper page
  25. Lawson, 2008, Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: Association with altered surfactant protein processing and herpesvirus infection, Am. J. Physiol Lung Cell Mol. Physiol, 294, L1119, 10.1152/ajplung.00382.2007 · DOI · Paper page
  26. Bueno, 2012, Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis, Am. J. Respir. Cell Mol. Biol., 46, 748, 10.1165/rcmb.2011-0224OC · DOI · Paper page
  27. Beller, 2004, Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis, Proc. Natl. Acad. Sci. USA, 101, 3047, 10.1073/pnas.0400235101 · DOI
  28. Phan, 1987, Leukotriene C4 binds to rat lung fibroblasts and stimulates collagen synthesis, Adv. Prostaglandin Thromboxane Leukot Res., 17B, 997
  29. Smirnova, 2016, Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs, Respir. Res., 17, 83, 10.1186/s12931-016-0404-x · DOI · Paper page
  30. Xu, 2016, Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis, JCI Insight, 1, e90558, 10.1172/jci.insight.90558 · DOI · Paper page
  31. Mora, 2017, Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis, J. Clin. Investig., 127, 405, 10.1172/JCI87440 · DOI · Paper page
  32. Cheng, P., Li, S., and Chen, H. (2021). Macrophages in Lung Injury, Repair, and Fibrosis. Cells, 10. · DOI · Paper page
  33. Takenouchi, 2020, Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts, Exp. Cell Res., 391, 112010, 10.1016/j.yexcr.2020.112010 · DOI
  34. Chung, 2021, IGF-1 Receptor Signaling Regulates Type II Pneumocyte Senescence and Resulting Macrophage Polarization in Lung Fibrosis, Int. J. Radiat. Oncol. Biol. Phys., 110, 526, 10.1016/j.ijrobp.2020.12.035 · DOI
  35. Rana, 2020, PAI-1 Regulation of TGF-beta1-induced Alveolar Type II Cell Senescence, SASP Secretion, and SASP-mediated Activation of Alveolar Macrophages, Am. J. Respir. Cell. Mol. Biol., 62, 319, 10.1165/rcmb.2019-0071OC · DOI · Paper page
  36. Popescu, 2019, Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres, Am. J. Respir. Crit. Care Med., 199, 362, 10.1164/rccm.201805-0825OC · DOI
  37. Cardenes, 2018, Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis, Stem Cell Res. Ther., 9, 257, 10.1186/s13287-018-0970-6 · DOI · Paper page
  38. Liu, 2020, Senescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy, Curr. Mol. Biol Rep., 6, 173, 10.1007/s40610-020-00141-0 · DOI · Paper page
  39. Antoniou, 2021, Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care, Curr. Opin. Pharmacol., 57, 71, 10.1016/j.coph.2020.12.007 · DOI
  40. Martel, 2020, Emerging use of senolytics and senomorphics against aging and chronic diseases, Med. Res. Rev., 40, 2114, 10.1002/med.21702 · DOI · Paper page
  41. Eid, 2010, AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes, J. Biol. Chem., 285, 37503, 10.1074/jbc.M110.136796 · DOI · Paper page
  42. Feng, 2006, Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence, Cell Cycle, 5, 2812, 10.4161/cc.5.23.3526 · DOI · Paper page
  43. Summer, 2019, Activation of the mTORC1/PGC-1 axis promotes mitochondrial biogenesis and induces cellular senescence in the lung epithelium, Am. J. Physiol. Lung Cell Mol. Physiol., 316, L1049, 10.1152/ajplung.00244.2018 · DOI · Paper page
  44. Zhang, X., Dong, Y., Li, W.C., Tang, B.X., Li, J., and Zang, Y. (2021). Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells. Acta Pharmacol. Sin. · DOI
  45. Kuehl, 2018, BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts, Matrix Biol., 68, 94, 10.1016/j.matbio.2018.01.020 · DOI · Paper page
  46. Pan, 2017, Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice, Int J. Radiat. Oncol. Biol. Phys., 99, 353, 10.1016/j.ijrobp.2017.02.216 · DOI · Paper page
  47. Kaefer, 2014, Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia, Cancer Chemother. Pharmacol., 74, 593, 10.1007/s00280-014-2530-9 · DOI · Paper page
  48. Plate, 2020, The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis, Eur. Respir. Rev., 29, 200269, 10.1183/16000617.0269-2020 · DOI
  49. Jarman, 2014, An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model, Am. J. Respir. Cell Mol. Biol., 50, 158, 10.1165/rcmb.2013-0174OC · DOI · Paper page

Cited by

Metadata

Authors
Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-06-29
Volume
22
Issue
13
Pages
7012
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3176748518
Cited by
76
References
68
FWCI
6.52
Type
journal article
Language
en
Open access
gold
Funders
  • Instituto de Salud Carlos III (SLT008/18/00176)
  • Federación Española de Enfermedades Raras (PI17/00369, 452 PI18/1008, PI19/01152)
  • Miguel Servet Research contract (CP16/00039)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.